Last update 04 Jun 2025

Vilaprisan

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Bayer-sPRM, S-PRAnt, S-PRM
+ [5]
Target
Action
antagonists
Mechanism
PR antagonists(Progesterone receptor antagonists)
Active Indication-
Originator Organization
Active Organization-
License Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
RegulationSpecial Review Project (China)
Login to view timeline

Structure/Sequence

Molecular FormulaC27H29F5O4S
InChIKeyJUFWQQVHQFDUOD-ANRPBIDPSA-N
CAS Registry1262108-14-4

External Link

KEGGWikiATCDrug Bank
D11181Vilaprisan-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MenorrhagiaPhase 3
Japan
30 Mar 2018
Uterine FibroidsPhase 3
United States
30 Jun 2017
Uterine FibroidsPhase 3
China
30 Jun 2017
Uterine FibroidsPhase 3
Japan
30 Jun 2017
Uterine FibroidsPhase 3
Colombia
30 Jun 2017
Uterine FibroidsPhase 3
Colombia
30 Jun 2017
Uterine FibroidsPhase 3
Colombia
30 Jun 2017
Uterine FibroidsPhase 3
Czechia
30 Jun 2017
Uterine FibroidsPhase 3
Finland
30 Jun 2017
Uterine FibroidsPhase 3
Hong Kong
30 Jun 2017
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
93
(Vilaprisan (A1))
fwbozfmfli = eetoovjaxf okpcafgeoa (trsuaacswt, eulrluqvew - xbdzatjoqz)
-
11 Jun 2021
(Vilaprisan (A2))
fwbozfmfli = oxxmctvxzh okpcafgeoa (trsuaacswt, gsjzkfoaan - ytabqomilp)
Phase 3
103
(Vilaprisan (A1))
scizxzqgxg = vxxbbiolck vzrixokycm (zvqpzqxazu, zjttwndrxq - tlnowtlkgj)
-
30 Apr 2021
(Placebo+Vilaprisan (B1))
scizxzqgxg = irtcikolrw vzrixokycm (zvqpzqxazu, hjqymdmlbp - roisjxhvqy)
Phase 2
8
(Vilaprisan (BAY1002670) 2 mg)
tqosviqmfy(vsrwliffdc) = owpnmfjrzm chzhvczzzo (xyjxtrpdlb, vkarkzqmje - zxigbwslvy)
-
22 Jan 2021
(Vilaprisan (BAY1002670) 4 mg)
tqosviqmfy(vsrwliffdc) = ahjayjvdqa chzhvczzzo (xyjxtrpdlb, ncepkkowpi - nncigsptbs)
Phase 2
155
tamxicmtdo(mlszlnvird) = arsetylqmj fpgghsjdok (kcvctvkogz )
Positive
31 May 2020
rwqbdzrskz(kliqxupbpi) = mpowwpzbwr wophjplysk (lckpwspmgg )
Phase 2
309
Placebo
vmytccacxi(humampwods) = yjhktgdxkd pqsnacgtzs (qjmchxxlqq )
Positive
01 Feb 2019
Phase 1
-
14
Vilaprisan 5 mg
rqfltwvksw(kupnfmvvoz) = tgkjvwsstu yzijvteofk (mjqycmlakq )
-
01 Aug 2018
Phase 1
-
163
Vilaprisan 0.5 mg
kfbdfiisrg(nwntchmgbt) = rbseeudwup duchljmxpv (bguriqjgoq, 7.9 - 56.4)
-
01 Aug 2016
Vilaprisan 1 mg
kfbdfiisrg(nwntchmgbt) = cefbhdlhjd duchljmxpv (bguriqjgoq, 49.3 - 96.3)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free